We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 08, 2014

Predictors of Risk of Progression to Myeloma



Additional Info

Clinical, Genomic, and Imaging Predictors of Myeloma Progression From Asymptomatic Monoclonal Gammopathies (SWOG S0120)
Blood 2014 Jan 02;123(1)78-85, MV Dhodapkar, R Sexton, S Waheed, S Usmani, X Papanikolaou, B Nair, N Petty, JD Shaughnessy, A Hoering, J Crowley, RZ Orlowski, B Barlogie

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.